In this case study, large health systems implement IBM Watson Health to surface improvement opportunities. Using this tool, they were able to cut costs, reduce patients’ length of stay, acquire actionable data, address number of readmissions and improve management of COPD and sepsis.
Like healthcare organizations elsewhere, reducing readmissions had become a top priority by 2011. Advocate, the state’s largest healthcare provider, had just signed its first shared savings agreement with Blue Cross Blue Shield of Illinois to become one of the first commercial accountable care organizations (ACOs) in the country. This event, along with others such as signing up as a Medicare Shared Savings Provider, led to re-evaluating the care continuum throughout Advocate Health’s 250 sites of care, including 13 acute-care hospitals, two children’s hospitals and a growing home healthcare division.
Population health initiatives are helping to lower healthcare costs and improve quality. As a result, 85% of hospitals reported strong or total commitment to population health. This year, hospital readmissions should be a top priority.
Published By: Polycom
Published Date: Mar 13, 2015
For those suffering from chronic or long-term health problems, there is often nothing quite as relieving as being sent home from the hospital—but also nothing quite as heartbreaking as readmission. Unfortunately, it is not unusual. Patients are sent home with instructions to continue improving their health, but few manage to do everything they need to do for a variety of reasons. Thankfully, there are ways to prevent this readmission.
Carson Tahoe Health needed insights to convince its board that an outpatient palliative care program could help address its higher-thanaverage mortality rates and help decrease the risk of future financial impact from those rates
The healthcare system used IBM® CareDiscovery to track and analyze end-stage patient mortality and related length of stay, readmissions, utilization and costs in key disease groups—by comparing those who participated in trial inpatient palliative care and those who did not
The analysis was used to demonstrate to the system’s board that an outpatient palliative care service line was viable in terms of both cost savings and quality-of-care improvement